Form 4: Zivo Bioscience Director Christopher D. Maggiore Reports Transactions in Company Stock

Sentiment:

SEC Form 4


Director Christopher D. Maggiore reports acquisition and disposal of Zivo Bioscience stock and cancellation of stock options.

Summary

  • Christopher D. Maggiore, a director of Zivo Bioscience, Inc., reported transactions involving the company's stock on June 5, 2024.
  • Maggiore acquired 36,630 shares of common stock and 81,544 shares at a price of $7.96.
  • He also disposed of nonstatutory stock options for 15,867 shares in exchange for 36,630 shares of restricted stock.
  • Following these transactions, Maggiore beneficially owns 454,990 shares of Zivo Bioscience common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating neutral sentiment as it reports transactions without expressing opinions or forecasts.

Key Dates

DateDescription
10/12/2021Date of original grant of some of the stock options that were later cancelled.
10/21/2021Date of original grant of some of the stock options that were later cancelled.
7/28/2022Date of original grant of some of the stock options that were later cancelled.
12/16/2022Date of original grant of some of the stock options that were later cancelled.
6/12/2023Date of original grant of some of the stock options that were later cancelled.
10/20231 for 6 reverse stock split of the Issuer's stock.
06/05/2024Date of stock acquisition and disposal transactions and cancellation of stock options.
06/06/2024Date of report.
10/11/2031Expiration date of some of the cancelled stock options.
10/20/2031Expiration date of some of the cancelled stock options.
07/27/2032Expiration date of some of the cancelled stock options.
12/15/2032Expiration date of some of the cancelled stock options.
06/11/2033Expiration date of some of the cancelled stock options.

Keywords

Zivo Bioscience, Christopher Maggiore, stock transactions, Form 4, beneficial ownership, stock options, restricted stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.